| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 07/23/2008 | CN101224201A Application of dual inhibitor for dopamine and norepinephrine transfer protein |
| 07/22/2008 | US7402595 JNK inhibitor |
| 07/22/2008 | US7402577 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/22/2008 | US7402560 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/22/2008 | US7402430 Preparing synthetic antigen presenting matrix/biological scaffold comprising immobilized major histocompatibility complex for use in identifying modulator for treatment and prevention of autoimmune, allergy and cancer disorders |
| 07/22/2008 | CA2383011C Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 07/17/2008 | WO2008084368A2 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy |
| 07/17/2008 | US20080171762 Treatment of pain with naloxone |
| 07/17/2008 | US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production |
| 07/17/2008 | CA2674296A1 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy |
| 07/16/2008 | EP1476151B1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders |
| 07/16/2008 | EP1471907B1 Use of c-kit inhibitors for treating autoimmune diseases |
| 07/16/2008 | EP1392264B1 Delivery of antiemetics through an inhalation route |
| 07/16/2008 | EP1392257B1 Delivery of antihistamines through an inhalation route |
| 07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
| 07/16/2008 | EP1090122B1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 07/16/2008 | CN101220098A Neutralizing antibodies against GDF-8 and uses therefor |
| 07/15/2008 | US7399780 pyridin-2-yl-1H-indole or pyrimidin-4-yl-1H-indole derivatives; enzyme inhibitor of glycogen synthase kinase-3; treating dementia, Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis, corticobasal degeneration, Down syndrome, Huntington's Disease |
| 07/15/2008 | US7399463 HSA-free formulations of interferon-beta |
| 07/15/2008 | CA2395530C Calcium formate for use as a phosphorus binder and a dietary supplement |
| 07/10/2008 | WO2008081989A1 Nerve regeneration agent |
| 07/10/2008 | US20080167367 Stable hydrate of a muscarinic receptor antagonist |
| 07/10/2008 | US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors |
| 07/10/2008 | US20080167258 Genetically engineered RNA self replicating enzyme for use in removal of repetitve triplet codon associated with muscular dystrophy; gene therapeutics and RNA targeting |
| 07/10/2008 | US20080167248 Anti-Aging Effects Of Substance P |
| 07/10/2008 | US20080167222 Use of Growth Hormone Releasing Factor Analogs in Treating Patients Suffering From Wasting |
| 07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
| 07/09/2008 | EP1941898A2 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 07/09/2008 | EP1940518A1 Milk derived composition and use to enhance muscle mass or muscle strength |
| 07/09/2008 | EP1940408A1 ADENOSINE A2a RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXTRA-PYRAMIDAL SYNDROME AND OTHER MOVEMENT DISORDERS |
| 07/09/2008 | EP1603580B1 Composition for administration of iron for the treatment of restless legs syndrome |
| 07/09/2008 | EP1043023B1 Viscous compositions containing carbon dioxide |
| 07/09/2008 | EP0970121B1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
| 07/09/2008 | CN100400549C Nerve growth factor combined with collagen specificity and its coading gene and application |
| 07/08/2008 | US7396859 Perturbed membrane-binding compounds |
| 07/08/2008 | US7396848 oxazole derivatives to treat diabetic neuropathy and/or other kinds of peripheral neuropathy; 4-(4-chlorophenyl)-5-[3-(2-methoxyphenoxy)propyl]-2-(2-methyl-1-imidazolyl)oxazole |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2372377C A novel inhibitor of beta amyloid cleavage enzyme |
| 07/08/2008 | CA2285380C Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-amino-ethanesulfonic acid |
| 07/08/2008 | CA2280770C Gene therapy for alleviating erectile dysfunction |
| 07/03/2008 | WO2008078715A1 Therapeutic agent for inflammatory myopathy containing il-6 antagonist as active ingredient |
| 07/03/2008 | WO2008078411A1 Pharmaceutical agent for prevention and/or treatment of inflammatory myopathy |
| 07/03/2008 | WO2008077170A2 Benzothioamides, and use thereof for relaxing smooth muscles |
| 07/03/2008 | US20080161329 Pharmaceutical uses |
| 07/03/2008 | US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/03/2008 | US20080161226 Activatable Clostridial Toxins |
| 07/03/2008 | US20080160110 Anti-Aging Cosmetic Composition |
| 07/03/2008 | US20080160108 Method of treating muscular dystrophies with an inhibitor of histone deacetylase |
| 07/03/2008 | US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1938824A1 Medicine, food and drink or feed containing sphingomyelin |
| 07/02/2008 | EP1938814A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
| 07/02/2008 | EP1937232A2 Nutraceutical composition for the treatment of muscle wasting |
| 07/02/2008 | EP1824488A4 Phycotoxins and uses thereof |
| 07/02/2008 | EP1802250A4 Methods of treating wounds with gonyautoxins |
| 07/02/2008 | EP1539166B1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | EP1474425B9 Deazapurines and uses thereof |
| 07/02/2008 | EP1296940B1 Amidine derivatives as selective antagonists of nmda receptors |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398093C Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 07/01/2008 | US7393925 structural modification alters the biological persistence, preferably the biological half-life |
| 07/01/2008 | US7393872 Sodium channel blocker compositions and the use thereof |
| 07/01/2008 | US7393857 Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases |
| 07/01/2008 | US7393830 Prolactin induced increase in neural stem cell numbers |
| 07/01/2008 | US7393655 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 06/26/2008 | WO2008040550A3 Olive extracts for promoting muscle health |
| 06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
| 06/26/2008 | US20080153820 pharmaceutically acceptable salt thereof or prodrug thereof, and the use thereof in therapy and in the treatment or prevention of a disorder in which the blocking of purine receptors, particularly adenosine receptors and more particularly A2A receptors, may be beneficial, |
| 06/26/2008 | US20080153806 diagnostic test and method is provided comprising mixing blood or another biological fluid sample with a test compound and spotting the blood on filter paper for subsequent analysis of the effect of the test compound on the blood. The biological fluid can be a cerebrospinal |
| 06/26/2008 | US20080153788 Two ketosteroids of 3,17-diketoandrost-1,4,6-triene, 6-methylene-3-keto-17-hydroxylandrost-1,4-diene, 6-bromo-alpha-3,17-diketoandrost-1,4-diene and 6-bromo-beta-3,17-diketoandrost-1,4-diene and a carrier |
| 06/26/2008 | US20080152739 Botulinum toxins |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1877058A4 Use of phycotoxins in veterinary applications |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1328271B1 Treatment of neurological and neuropsychological disorders |
| 06/25/2008 | CN101204577A Process for preparing crystal composite of BTX-A |
| 06/25/2008 | CN101204377A Novel cryoprotectants prescription for treatment of botulinum toxin a freeze-dried powder and injection preparation |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2008 | US7390808 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes |
| 06/24/2008 | US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation |
| 06/24/2008 | US7390484 Self-contained adipose derived stem cell processing unit |
| 06/19/2008 | WO2008073466A2 Alpha b-crystallin as a therapy for inflammation |
| 06/19/2008 | WO2008072663A1 Composition for amelioration/prevention of adverse side effect in steroid therapy |
| 06/19/2008 | WO2008030505A3 Methods and compositions for the treatment of antibody mediated neuropathies |
| 06/19/2008 | US20080146635 Selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; treating pain, visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 06/19/2008 | US20080146619 Certain chemical entities, compositions, and methods |
| 06/19/2008 | US20080146585 Use Of C-Kit Inhibitors For Treating Inflammatory Muscle Disorders Including Myositis And Muscular Dystrophy |
| 06/19/2008 | US20080146561 Certain chemical entities, compositions and methods |
| 06/19/2008 | US20080146506 Methods of Suppressing Microglial Activation |
| 06/19/2008 | US20080145884 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 06/19/2008 | US20080145449 Thiol reactive agents as a therapeutic modality |
| 06/18/2008 | EP1931372A1 Method of treating myasthenia gravis |
| 06/18/2008 | EP1931349A2 Use of sodium channel blockers for the management of musculoskeletal pain |
| 06/18/2008 | EP1931223A1 Nutrition comprising betaine against muscle wasting |
| 06/18/2008 | EP1443937B1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |